Adolescents’ Understanding of Opioid-Induced Euphoria Measures and Proposed Measurement Revisions

References

• Albert, D., and L. Steinberg. 2011. Judgment and decision making in adolescence. Journal of Research on Adolescence 21 (1):211–14. doi:10.1111/j.1532-7795.2010.00724.x.
   Web of Science ®Google Scholar
• Altakhaineh, A.R.M. 2018. The semantic change of positive vs. negative adjectives in modern English. Lingua Posnaniensis 60 (2):25–38. doi:10.2478/linpo-2018-00010
   Google Scholar
• Baker, D. W. 2017. History of the joint commissions pain standards lessons for today’s prescription opioid epidemic. JAMA 317 (11):1117–18. doi:10.1001/jama.2017.0935.
   PubMed Web of Science ®Google Scholar
• Bieber, C. M., K. Fernandez, M. J. Brennan, R. N. Jamison, J. Sharpe-Potter, H. N. Thomson, R. D. Weiss, and N. P. Katz. 2008. Retrospective accounts of initial subjective effects of opioid in patients treated for pain who do or do not develop opioid addiction: A pilot case-control study. Experimental and Clinical Psychopharmacology 16:429–34. doi:10.1037/1064-1297.16.5.429.
   PubMed Web of Science ®Google Scholar
• Carter, L. P., J. E. Henningfield, Y. G. Wang, Y. Lu, D. Kelsh, B. Vince, and E. Sellers. 2018. A randomized, double-blind, placebo-controlled, crossover study to evaluate the human abuse liability of solriamfetol, a selective dopamine and norepinephrine reuptake inhibitor. Journal of Psychopharmacology 32:1351–61. doi:10.1016/j.drugalcdep.2009.04.003.
   PubMed Web of Science ®Google Scholar
• Carter, L. P., and R. R. Griffiths. 2009. Principles of laboratory assessment of drug abuse liability and implications for clinical development. Drug and Alcohol Dependency 10:131–46. doi:10.1016/j.drugalcdep.2009.04.003.
   Google Scholar
• Centers for Disease Control and Prevention (CDC). 2019. Annual surveillance report of drug-related risks and outcomes — United States surveillance special report. Centers for Disease Control and Prevention, U.S. Department of Health and Human Services. Accessed November 1, 2019. https://www.cdc.gov/drugoverdose/pdf/pubs/2019-cdc-drug-surveillancereport.pdf.
   Google Scholar
• Comer, S. D., and C. M. Cahill. 2019. Fentanyl: Receptor pharmacology, abuse potential, and implications for treatment. Neuroscience and Biobehavioral Review 106:49–57. doi:10.1016/j.neubiorev.2018.12.005.
   PubMed Web of Science ®Google Scholar
• Comer, S. D., J. P. Zacny, R. H. Dworkin, D. C. Turk, G. E. Bigelow, R. W. Foltin, D. R. Jasinski, E. M. Sellers, E. H. Adams, R. Balster, et al. 2012. Core outcome measures for opioid abuse liability laboratory assessment studies in humans: IMMPACT recommendations. Pain 153:2315–24. doi:10.1016/j.pain.2012.07.035.
   PubMed Web of Science ®Google Scholar
• Cruz, H., P. However, B. Chakraborty, K. Schoedel, E. Sellers, and J. Dingemanse. 2014. Assessment of the abuse liability of a dual orexin receptor antagonist: A crossover study of almorexant and zolpidem in recreational drug users. CNS Drugs 28:361–72. doi:10.1007/s40263-014-0150-x.
   PubMed Web of Science ®Google Scholar
• Fortuna, R. J., B. W. Robbins, E. Caiola, M. Joynt, and J. S. Halterman. 2010. Prescribing of controlled medications to teens and young adults in the United States. Pediatrics 126:1108–16. doi:10.1542/peds.2010-0791.
   PubMed Web of Science ®Google Scholar
• Geisler, M., L. Eichelkraut, W. H. R. Miltner, and T. Weiss. 2019. An fMRI study on runner’s high and exercise-induced hypoalgesia after a 2-h-run in trained non-elite male athletes. Sport Sciences for Health. doi:10.1007/s11332-019-00592-8.
   Google Scholar
• Gourlay, D. L., H. A. Heit, and A. Almahrezi. 2005. Universal precautions in pain medicine: A rational approach to the treatment of chronic pain. Pain Medicine 6:107–12. doi:10.1111/j.1526-4637.2005.05031.x.
   PubMed Web of Science ®Google Scholar
• Grieve, J., N. Andrea, and D. Gou. 2016. Analyzing lexical emergence in modern American English online. English Language and Linguistics 21:99–127. doi:10.1017/S1360674316000113.
   Web of Science ®Google Scholar
• Haertzen, C. A., and J. E. Hickey. 1987. Addiction Research Center Inventory (ARCI): Measurement of euphoria and other drug effects. In Methods of assessing the reinforcing properties of abused drugs, ed. M. A. Bozarth, 489–524. New York: Springer-Verlag.
   Google Scholar
• Hawkins, K. L., and B. E. Gidal. 2017. When adverse effects are seen as desirable: Abuse potential of the newer generation antiepileptic drugs. Epilepsy & Behavior 77 (62):62–72. doi:10.1016/j.yebeh.2017.10.007.
   PubMedGoogle Scholar
• Hicks, S. D., P. Jacob, O. Perez, M. Baffuto, Z. Gagnon, and F. A. Middleton. 2019. The transcriptional signature of a runner’s high. Medicine and Science in Sports and Exercise 51:970–78. doi:10.1249/MSS.0000000000001865.
   PubMed Web of Science ®Google Scholar
• Iqbal, S., and L. Pipon-Young. 2009. The Delphi method. A step-by-step guide. Psychologist 22 (7):598–600.
   Web of Science ®Google Scholar
• Jasinski, D. R. 1977. Assessment of the abuse potentiality of morphine-like drugs (methods used in man). In Drug addiction, ed. W. R. Martin, 197–258. New York: Springer-Verlag.
   Google Scholar
• Jordan, A. E., N. A. Blackburn, D. C. Des Jarlais, and H. Hagan. 2017. Past-year prevalence of prescription opioid misuse among those 11 to 30 years of age in the United States: A systematic review and meta-analysis. Journal of Substance Abuse Treatment 77:31–37. doi:10.1016/j.jsat.2017.03.007.
   PubMed Web of Science ®Google Scholar
• Kelly, S. M., J. Gryczynski, S. G. Mitchell, A. Kirk, K. E. O’Grady, and R. P. Schwartz. 2014. Validity of brief screening instrument for adolescent tobacco, alcohol, and drug use. Pediatrics 133:819–26. doi:10.1542/peds.2013-2346.
   PubMed Web of Science ®Google Scholar
• Levy-Cooperman, N., K. A. Schoedel, B. Chakraborty, D. Blum, and H. Cheng. 2016. Abuse liability assessment of eslicarbazepine acetate in healthy male and female recreational sedative users: A phase I randomized controlled trial. Epilepsy & Behavior 61:63–71. doi:10.1016/j.yebeh.2016.05.010.
   PubMed Web of Science ®Google Scholar
• Lisdahl, K. M., K. J. Sher, K. P. Conway, R. Gonzalez, S. W. Feldstein Ewing, S. J. Nixona, and M. Heitzeg. 2018. Adolescent brain cognitive development (ABCD) study: Overview of substance use assessment methods. Developmental Cognitive Neurosciences 32:80–96. doi:10.1016/j.dcn.2018.02.007.
   PubMed Web of Science ®Google Scholar
• Martin, C. A., G. Guenthner, C. Bingcang, M. K. Rayens, and T. H. Kelly. 2007. Measurement of the subjective effects of methylphenidate in 11-to 15-year-old children with attention deficit/ hyperactivity disorder. Journal of Child and Adolescent Psychopharmacology 17 (1):6–73. doi:10.1089/cap.2006.0020.
   Web of Science ®Google Scholar
• Martin, W. R., B. S. Sloa, J. D. Sapir, and D. R. Jasinski. 1971. Physiologic, subjective and behavioral effects of amphetamine, methamphetamine, ephedrine, phenmetrazine, and methylphenidate in man. Clinical Pharmacology and Therapeutics 12:245–58. doi:10.1002/cpt1971122part1245.
   PubMed Web of Science ®Google Scholar
• Martins, S. S., L. E. Segura, J. Santaella-Tenorio, A. Perimutter, M. C. Fenton, M. Cerda, K. M. Keyes, L. A. Ghandour, C. L. Storr, and D. S. Hasin. 2017. Prescription opioid use disorder and heroin use among 12–34-year-olds in the United States from 2002 to 2014. Addiction Behaviors 65:236–41. doi:10.1016/j.addbeh.2016.08.033.
   PubMed Web of Science ®Google Scholar
• McCabe, S. E., B. T. West, C. J. Teter, and C. J. Boyd. 2012. Medical and nonmedical use of prescription opioids among high school seniors in the United States. Archives of Pediatrics & Adolescent Medicine 166:797–802. doi:10.1001/archpediatrics.2012.85.
   PubMed Web of Science ®Google Scholar
• Miech, R., L. Johnston, P. M. O’Malley, K. M. Keyes, and K. Heard. 2015. Prescription opioids in adolescence and future opioid misuse. Pediatrics 136:e1169–77. doi:10.1542/peds.2015-1364.
   PubMed Web of Science ®Google Scholar
• Mokknik, L. B., C. B. Terwee, D. L. Patrick, J. Alonso, P. W. Stratford, D. L. Know, L. M. Bouter, and H. C. W. De Vet. 2010. The COSMIN checklist for assessing the methodological quality of studies on measurement properties of health status measurement instruments: An international Delphi study. Quality of Life Research 19:539–49. doi:10.1001/s11136-010-9606-8.
   PubMed Web of Science ®Google Scholar
• Morean, M. E., H. deWit, A. C. King, M. Souoglu, S. Y. Rueger, and S. S. O’Malley. 2013. The drug effects questionnaire: Psychometric support across three drug types. Psychopharmacology 227:177–92. doi:10.1007/s00213-012-2954-z.
   PubMed Web of Science ®Google Scholar
• Nippold, M. A. 2000. Language development during the adolescent years: Aspects of pragmatics, syntax, and semantics. Topics in Language Disorders 20:15–28. doi:10.1097/00011363-200020020-00004.
   Web of Science ®Google Scholar
• Nippold, M. A., L. D. Uhden, and L. E. Schwarz. 1997. Proverb explanation through the lifespan: A developmental study of adolescents and adults. Journal of Speech, Language, and Hearing Research 40:245–53. doi:10.1044/jslhr.4002.245.
   PubMed Web of Science ®Google Scholar
• Nogueira, A., O. Molinero, A. Salguero, and S. Marquez. 2018. Exercise addiction in practitioners of endurance sports: A literature review. Frontiers in Psychology 9:1484. doi:10.3389/fpsyg.2018.01484.
   PubMed Web of Science ®Google Scholar
• Raichlen, D., A. Foster, G. Gerdeman, A. Seillier, and A. Giuffrida. 2012. Wired to run: Exercise-induced endocannabinoid signaling in humans and cursorial mammals with implications for the ‘runner’s high. Journal of Experimental Biology 215:1331–36. doi:10.1242/jeb.063677.
   PubMed Web of Science ®Google Scholar
• Reyna, V. F., and F. Farley. 2006. Risk and rationality in adolescent decision making: Implications for theory, practice, and public policy. Psychological Science in the Public Interest 7:1–44. doi:10.1111/j.1529-1006.2006.00026.x.
   PubMed Web of Science ®Google Scholar
• Szabo, A., M. D. Griffiths, R. D. L. V. Marcos, B. Mervó, and Z. Demetrovics. 2015. Focus: Addiction: Methodological and conceptual limitations in exercise addiction research. Yale Journal of Biology and Medicine 88:303–08.
   PubMedGoogle Scholar
• Tadros, A., S. M. Layman, S. M. Davis, R. Bozeman, D. M. Davidov. 2016. Emergency department visits by pediatric patients for poisoning by prescription opioids. American Journal of Drug and Alcohol Abuse 42:550–55. doi:10.1080/00952990.2016.1194851.
   PubMed Web of Science ®Google Scholar
• Trask, L. 2016. Why do languages change? United Kingdom: Cambridge University Press.
   Google Scholar
• Valle, M., A. E. Maqueda, M. Rabella, A. Rodriguez-Pujadas, R. M. Antonijoan, S. Romero, J. F. Alonso, M. A. Mananas, S. Barker, P. Friedlander, et al. 2016. Inhibition of alpha oscillations through serotonin-2A receptor activation underlies the visual effects of ayahuasca in humans. European Neuropsychopharmacology 26:1161–75. doi:10.1016/j.euroneuro.2016.03.012.
   PubMed Web of Science ®Google Scholar
• Voepel-Lewis, T., C. J. Boyd, S. E. McCabe, B. J. Zikmund-Fisher, S. Malviya, J. Grant, M. Weber, and A. R. Tait. 2018. Deliberative prescription opioid misuse among adolescents and emerging adults: Opportunities for targeted interventions. Journal of Adolescent Health 63 (5):594–600. doi:10.1016/j.jadohealth.2018.07.007.
   PubMed Web of Science ®Google Scholar
• Weafer, J., S. Gorka, D. Hedeker, M. Dzemidzic, D. Kareken, K. Phan, and H. De Wit. 2017. Associations between behavioral and neural correlates of inhibitory control and amphetamine reward sensitivity. Neuropsychopharmacology 42:1905–13. doi:10.1038/npp.2017.61.
   PubMed Web of Science ®Google Scholar